FDA Approves Targeted COVID Booster with Priority Distribution Plan
FDA approves 2025-2026 COVID boosters targeting JN.1 LP.8.1 variant with restricted access to priority groups including elderly,...
In health, Informed Clearly decodes fast-moving headlines into clear signal, strategic context, and practical consequences.
367 results • page 27 / 62
FDA approves 2025-2026 COVID boosters targeting JN.1 LP.8.1 variant with restricted access to priority groups including elderly,...
New research shows tropical regions face increasing zoonotic disease risks due to environmental changes. Experts call for better...
The 2025 WHO Pandemic Agreement establishes historic vaccine technology transfer obligations, creating regional production hubs and...
Europe's flu season started four weeks early due to a new H3N2 variant (subclade K), straining healthcare systems. Vaccines remain...
Schools are expanding mental health services through telehealth integration and workforce recruitment to address the youth mental health...
Recent FDA approvals of gene therapies like Beqvez and Kebilidi have sparked debates about million-dollar pricing and equitable access....